MannKind Corp
MNKD
#6092
Rank
NZ$1.98 B
Marketcap
NZ$6.17
Share price
-0.42%
Change (1 day)
-31.36%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -NZ$49.61 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.36 Billion. In 2025 the company made an earning of NZ$2.44 Million a decrease over its 2024 earnings that were of NZ$53.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$49.61 Million-2127.04%
2025 NZ$2.44 M-95.39%
2024 NZ$53.07 M-394.09%
2023 -NZ$18.05 Million-88.13%
2022 -NZ$0.16 Billion8%
2021 -NZ$0.15 Billion40.84%
2020 -NZ$99.94 Million10.7%
2019 -NZ$90.28 Million-40.16%
2018 -NZ$0.16 Billion-26.04%
2017 -NZ$0.21 Billion-193.33%
2016 NZ$0.21 B-134.11%
2015 -NZ$0.65 Billion85.72%
2014 -NZ$0.35 Billion3.6%
2013 -NZ$0.34 Billion12.79%
2012 -NZ$0.3 Billion5.58%
2011 -NZ$0.28 Billion-5.72%
2010 -NZ$0.3 Billion-22.51%
2009 -NZ$0.39 Billion-27.37%
2008 -NZ$0.53 Billion3.36%
2007 -NZ$0.51 Billion27.18%
2006 -NZ$0.41 Billion101.63%
2005 -NZ$0.2 Billion50.46%
2004 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.42 B-37,162.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$43.50 B-87,627.65%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$54.13 B-109,020.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.87 B-46,124.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$0.87 B-1,861.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.27 Billion 432.64%๐Ÿ‡บ๐Ÿ‡ธ USA